Jennifer Zinn is the Executive Vice President of Clinical Operations at bioMérieux. Prior to August 1, 2023, she was the General Manager & Head of Clinical Operations, North America where she oversaw the commercial operations of the US and Canada business. Jennifer has been a leader of change and improvement at Fortune 500 Healthcare organizations since 1996, culminating with senior leadership positions in commercial operations in four major diagnostics companies. Before joining bioMérieux in 2022, Jennifer was Executive Vice President and Head of Diagnostics, North America at Siemens Healthineers for three years. During this time, she successfully led the commercial organization across the entire laboratory and point-of-care portfolio. Prior to Siemens Healthineers, Jennifer was with Roche Diagnostics for 8.5 years, leading commercial operations with increasing responsibility, including driving the North America strategy, overseeing the Point-of-Care business, and then leading the specialty diagnostics business outside the hospital. Zinn had previously spent nine years in commercial operations at Ortho Clinical Diagnostics, culminating in leading North America marketing and overseeing the launch of their integrated chemistry/ immunoassay line.